Tokyo Medical and Dental University (TMDU) has developed the Life Course Consortium Concept, which identifies important research to be promoted and supports medical and dental studies that cover many aspects of human life. After establishing the ‘Organ and Tissue Neogenesis’ Consortium in 2017, the ‘Medical Innovation' Consortium was launched in 2018.
　　　Medical research that utilizes genomic information, including cancer genomic medicine, is one of the research fields in which the university excels, in both basic and clinical aspects. In April 2020, the M&D Data Science Center will be established as a research and education center for data science in the medical and dental fields.
Data science is expected to further support genomic medical research.
　　　TMDU has strengths not only in genomic medical research and data science, but also in cell-structure physiology research using cryo-electron microscopy, drug discovery fields such as oligonucleotide and mRNA medicine, and efficient genome-editing technology. The ‘Medical Innovation’ Consortium has a mission to bring together these technological capabilities of the university and implement future medical technologies in society. A kick-off symposium was held on December 9, 2019.

The Medical Innovation Consortium consists of three organizations:

1 The Basic and Exploratory Science Division searches for undiscovered genome functions and develops new knowledge and technology.

2 The Applied and Clinical Science Division develops therapeutics for refractory diseases, cancer and lifestyle-related diseases.

3 The Information Integration Core Unit brings together multi-layered information for future medicine. It provides big-data analysis technology and processes highquality biological samples and clinical information collected by the Bio Research Center. It also provides support on bioethical issues and acts as a bridge between the two other organizations in the Life Course Consortium.